Association of the platelet glycoprotein receptor IIIa (PI A1/PIA1) genotype with coronary artery disease in Arabs

Blood Coagulation and Fibrinolysis

Volumn 15, Issue 1, 2004, Pages 77-79

  Abu Amero, Khaled K ^a   Wyngaard, Carol A ^a   Dzimiri, Nduna ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

Arabs; Coronary artery disease; Genotype; Platelet glycoprotein

Indexed keywords

FIBRINOGEN RECEPTOR; GLYCOPROTEIN IIIA; PLATELET GLYCOPROTEIN RECEPTOR IIIA; UNCLASSIFIED DRUG;

ADULT; ALLELE; ANGIOGRAPHY; ARAB; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ETHNOLOGY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION MAPPING;

ALLELES; ARABS; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HOMOZYGOTE; INTEGRIN BETA3; POLYMERASE CHAIN REACTION; SAUDI ARABIA;

EID: 2042442457     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200401000-00012     Document Type: Article

References (21)

1. Wu AH, Tsongalis GJ. Correlation of polymorphisms to coagulation and biochemical risk factors for cardiovascular diseases. Am J Cardiol 2001; 87:1361-1366.
2. Abu-Amero KK, Wyngaard CA, Al-Boudari OM, Kambouris M, Dzimiri N. Lack of association of lipoprotein lipase gene polymorphisms with coronary artery disease in the Saudi Arab population. Arch Pathol Lab Med 2003; 127:597-600.
3. Abu-Amero KK, Wyngaard CA, Kambouris M, Dzimiri N. Prevalence of the 20210 G → A prothrombin variant and its association with coronary artery disease in a Middle Eastern Arab population. Arch Pathol Lab Med 2002; 126:1087-1090.
4. Newman PJ, Derbes RS, Aster RH. The human platelet alloantigens, PIA1 and PIA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing. J Clin Invest 1989; 83:1778-1781.
5. Gruchala M, Ciecwierz D, Ochman K, Targonski R, Dubaniewicz W, Sobiczewski W, et al. Association between the PI(A) platelet glycoprotein GPIIIa polymorphism and extent of coronary artery disease. Int J Cardiol 2003; 88:229-237.
6. Bray PF, Cannon CP, Goldschmidt-Clermont P, Moye L, Pfeffer M, Sacks F, et al. The platelet PI(A2) and angiotensin-converting enzyme (ACE) D allele polymorphisms and the risk of recurrent events after acute myocardial infarction. Am J Cardiol 2001; 88:347-352.
7. Di Castelnuovo A, de Gaetano G, Donati MB, Iacoviello L. Platelet glycoprotein receptor IIIa polymorphism PLA1/PLA2 and coronary risk: a meta-analysis. Thromb Haemost 2001; 85:626-633.
8. Mikkelsson J, Perola M, Penttila A, Goldschmidt-Clermont PJ, Karhunen PJ. The GPIIIa (beta3 integrin) PIA polymorphism in the early development of coronary atherosclerosis. Atherosclerosis 2001; 154:721-727.
9. Mikkelsson J, Perola M, Laippala P, Savolainen V, Pajarinen J, Lalu K, et al. Glycoprotein IIIa PI(A) polymorphism associates with progression of coronary artery disease and with myocardial infarction in an autopsy series of middle-aged men who died suddenly. Arterioscler Thromb Vasc Biol 1999; 19:2573-2578.
10. Ito T, Ishida F, Shimodaira S, Kitano K. Polymorphisms of platelet membrane glycoprotein Ib alpha and plasma von Willebrand factor antigen in coronary artery disease. Int J Hematol 1999; 70:47-51.
11. Anderson JL, King GJ, Bair TL, Elmer SP, Muhlestein JB, Habashi J, et al. Associations between a polymorphism in the gene encoding glycoprotein IIIa and myocardial infarction or coronary artery disease. J Am Coll Cardiol 1999; 33:727-733.
12. Sperr WR, Huber K, Roden M, Janisiw M, Lang T, Graf S, et al. Inherited platelet glycoprotein polymorphisms and a risk for coronary heart disease in young central Europeans. Thromb Res 1998; 90:117-123.
13. Mamotte CD, van Bockxmeer FM, Taylor RR. PIa1/a2 polymorphism of glycoprotein IIIa and risk of coronary artery disease and restenosis following coronary angioplasty. Am J Cardiol 1998; 82:13-16.
14. Kekomaki S, Hamalainen L, Kauppinen-Makelin R, Palomaki H, Kaste M, Kontula K. Genetic polymorphism of platelet glycoprotein IIIa in patients with acute myocardial infarction and acute ischaemic stroke. J Cardiovasc Risk 1999; 6:13-17.
15. Cenarro A, Casao E, Civeira F, Jensen HK, Faergeman O, Pocovi M. P1A1/A2 polymorphism of platelet glycoprotein IIIa and risk of acute coronary syndromes in heterozygous familial hypercholesterolemia. Atherosclerosis 1999; 143:99-104.
16. Goldschmidt-Clermont PJ, Coleman LD, Pham YM, Cooke GE, Shear WS, Weiss EJ, et al. Higher prevalence of GPIIIa PIA2 polymorphism in siblings of patients with premature coronary heart disease. Arch Pathol Lab Med 1999; 123:1223-1229.
17. Goodall A, Curzen N, Panesar M, Hurd C, Knight C, Ouwehand W, et al. Increased binding of fibrinogen to glycoprotein IIIa-proline33 (HPA-1b, PIA2, Zwb) positive platelets in patients with cardiovascular disease. Eur Heart J 1999; 20:742-747.
18. Renner W, Winkler M, Hoffmann C, Koppel H, Seinost G, Brodmann M, et al. The PIA1/A2 polymorphism of platelet glycoprotein IIIa is not associated with deep venous thrombosis. Int Angiol 2001; 20:148-151.
19. Weiss EJ, Bray PF, Tayback M, Schulman SP, Kickler TS, Becker LC, et al. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med 1996; 334: 1090-1094.
20. Al-Humaidi MA. Probability of coronary artery disease among patients attending primary health care centers (PHCCs) in Southwest Saudi Arabia. Ethnic Dis 2000; 10:350-356.
21. Osman AK, al-Nozha MM. Risk factors of coronary artery disease in different regions of Saudi Arabia. East Mediterr Health J 2000; 6: 465-474.